Generali Investments Management Co LLC Invests $889,000 in Synopsys, Inc. (NASDAQ:SNPS)

Generali Investments Management Co LLC purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,832 shares of the semiconductor company's stock, valued at approximately $889,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Investment House LLC increased its stake in Synopsys by 247.9% during the 4th quarter. Investment House LLC now owns 4,989 shares of the semiconductor company's stock worth $2,421,000 after buying an additional 3,555 shares during the period. Platinum Investment Management Ltd. increased its position in shares of Synopsys by 39.8% in the 4th quarter. Platinum Investment Management Ltd. now owns 3,317 shares of the semiconductor company's stock worth $1,610,000 after purchasing an additional 944 shares during the last quarter. Xponance Inc. increased its position in shares of Synopsys by 2.8% in the 4th quarter. Xponance Inc. now owns 40,766 shares of the semiconductor company's stock worth $19,786,000 after purchasing an additional 1,129 shares during the last quarter. Generali Asset Management SPA SGR bought a new stake in shares of Synopsys in the 4th quarter worth about $5,189,000. Finally, Horizon Investments LLC increased its position in shares of Synopsys by 76.2% in the 4th quarter. Horizon Investments LLC now owns 6,671 shares of the semiconductor company's stock worth $3,238,000 after purchasing an additional 2,886 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.

Remove Ads

Insider Transactions at Synopsys

In related news, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the sale, the executive now directly owns 1,460 shares of the company's stock, valued at $738,774.60. This represents a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Geus Aart De sold 15,705 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the sale, the insider now owns 116,671 shares of the company's stock, valued at $51,850,925.82. The trade was a 11.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 47,909 shares of company stock valued at $22,794,835. Company insiders own 0.62% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on SNPS shares. Redburn Atlantic started coverage on shares of Synopsys in a research report on Monday, January 13th. They issued a "buy" rating and a $600.00 target price for the company. Rosenblatt Securities reissued a "buy" rating and issued a $660.00 target price on shares of Synopsys in a research report on Tuesday, February 25th. Piper Sandler dropped their target price on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Needham & Company LLC reaffirmed a "buy" rating and set a $650.00 price objective on shares of Synopsys in a research report on Thursday, February 27th. Finally, Morgan Stanley lowered their price objective on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a research report on Monday, February 24th. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, Synopsys currently has an average rating of "Moderate Buy" and an average price target of $638.58.

Synopsys Trading Down 0.3 %

Synopsys stock traded down $1.39 during midday trading on Friday, reaching $448.60. 3,362,089 shares of the stock traded hands, compared to its average volume of 1,020,823. The firm has a fifty day moving average price of $491.19 and a two-hundred day moving average price of $506.23. The firm has a market cap of $69.36 billion, a price-to-earnings ratio of 30.90, a PEG ratio of 3.23 and a beta of 1.16. Synopsys, Inc. has a fifty-two week low of $425.73 and a fifty-two week high of $624.80.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.